Interleukin-12-mediated resistance to Trypanosoma cruzi is dependent on tumor necrosis factor alpha and gamma interferon - PubMed (original) (raw)

Interleukin-12-mediated resistance to Trypanosoma cruzi is dependent on tumor necrosis factor alpha and gamma interferon

C A Hunter et al. Infect Immun. 1996 Jul.

Abstract

The aim of this study was to determine if interleukin-12 (IL-12) has a role in the immune response to Trypanosoma cruzi. Infection of BALB/c mice with the virulent Tulahuen strain of T. cruzi is characterized by a high-level parasitemia, pathology in the heart associated with the presence of amastigotes, and death during the acute phase of the disease. Administration of IL-12 to BALB/c mice infected with T. cruzi resulted in a reduced parasitemia and a significant delay in the time to death compared with those for infected controls. This protective effect was correlated with increased levels of gamma interferon (IFN-gamma) and tumor necrosis factor alpha (TNF-alpha) in serum. To determine if these cytokines were involved in the protective effects of IL-12, we treated infected mice with IL-12 alone or in combination with monoclonal antibodies specific for IFN-gamma or TNF-alpha. These antibodies antagonized the protective effect of exogenous IL-12. Treatment of infected mice with a polygonal antibody specific for IL-12 resulted in a significant increase in parasitemia but did not affect the time to death. These latter studies demonstrate a role for endogenous IL-12 in resistance to T. cruzi. Together, our data identify an IL-12-mediated mechanism of resistance to T. cruzi, which is dependent on IFN-gamma and TNF-alpha.

PubMed Disclaimer

Similar articles

• [TH1 response in the experimental infection with Trypanosoma cruzi].
  Cardoni RL, Antúnez MI, Abrami AA. Cardoni RL, et al. Medicina (B Aires). 1999;59 Suppl 2:84-90. Medicina (B Aires). 1999. PMID: 10668248 Spanish.
• Trypanosoma cruzi: IL-10, TNF, IFN-gamma, and IL-12 regulate innate and acquired immunity to infection.
  Abrahamsohn IA, Coffman RL. Abrahamsohn IA, et al. Exp Parasitol. 1996 Nov;84(2):231-44. doi: 10.1006/expr.1996.0109. Exp Parasitol. 1996. PMID: 8932773
• Macrophage migration inhibitory factor contributes to host defense against acute Trypanosoma cruzi infection.
  Reyes JL, Terrazas LI, Espinoza B, Cruz-Robles D, Soto V, Rivera-Montoya I, Gómez-García L, Snider H, Satoskar AR, Rodríguez-Sosa M. Reyes JL, et al. Infect Immun. 2006 Jun;74(6):3170-9. doi: 10.1128/IAI.01648-05. Infect Immun. 2006. PMID: 16714544 Free PMC article.
• [Role of cytokines in resistance and pathology in Trypanosoma cruzi infection].
  Laucella SA, Rottenberg ME, de Titto EH. Laucella SA, et al. Rev Argent Microbiol. 1996 Apr-Jun;28(2):99-109. Rev Argent Microbiol. 1996. PMID: 8768488 Review. Spanish.
• How are antibodies involved in the protective mechanism of susceptible mice infected with T. cruzi?
  Umekita LF, Mota I. Umekita LF, et al. Braz J Med Biol Res. 2000 Mar;33(3):253-8. doi: 10.1590/s0100-879x2000000300001. Braz J Med Biol Res. 2000. PMID: 10719375 Review.

Cited by

• Memory-like NK Cells Are a Critical Component of Vaccine-Induced Immunity to Trypanosoma cruzi Infection.
  Horta AL, Gigley J, Boutet M, Lavau G, Weiss LM, Huang H. Horta AL, et al. J Immunol. 2024 Feb 15;212(4):617-631. doi: 10.4049/jimmunol.2300509. J Immunol. 2024. PMID: 38197653
• The Role of MIF and IL-10 as Molecular Yin-Yang in the Modulation of the Host Immune Microenvironment During Infections: African Trypanosome Infections as a Paradigm.
  Stijlemans B, Schoovaerts M, De Baetselier P, Magez S, De Trez C. Stijlemans B, et al. Front Immunol. 2022 Apr 7;13:865395. doi: 10.3389/fimmu.2022.865395. eCollection 2022. Front Immunol. 2022. PMID: 35464430 Free PMC article. Review.
• Trypanosoma evansi evades host innate immunity by releasing extracellular vesicles to activate TLR2-AKT signaling pathway.
  Wei R, Li X, Wang X, Zhang N, Wang Y, Zhang X, Gong P, Li J. Wei R, et al. Virulence. 2021 Dec;12(1):2017-2036. doi: 10.1080/21505594.2021.1959495. Virulence. 2021. PMID: 34348595 Free PMC article.
• Effects of Cytokine Therapy for Treatment and Prophylaxis of Hydatidosis in Experimental Animal Model (Mice).
  Rahdar M, Rafiei A, Valipour Norouzi R. Rahdar M, et al. Iran J Parasitol. 2018 Oct-Dec;13(4):587-593. Iran J Parasitol. 2018. PMID: 30697312 Free PMC article.

References

1. 1. Infect Immun. 1994 May;62(5):1639-42 - PubMed
2. 1. Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6115-9 - PubMed
3. 1. Annu Rev Immunol. 1995;13:251-76 - PubMed
4. 1. Proc Natl Acad Sci U S A. 1994 Oct 25;91(22):10700-2 - PubMed
5. 1. J Immunol. 1986 Aug 15;137(4):1342-5 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations